InvestorsHub Logo
Followers 7
Posts 119
Boards Moderated 0
Alias Born 09/28/2015

Re: bennyboy1 post# 115412

Monday, 08/14/2017 3:11:33 PM

Monday, August 14, 2017 3:11:33 PM

Post# of 468842
Biogen is still pushing an awful drug for AD that they know barely works, yet some people on this board think that Biogen may have thrown in the towel with regards to a therapy for MS - their golden ticket therapeutic area which is now at risk due to Roche's new MS drug - which Anavex has already shown in some preclinical work to be efficacious for MS, that Biogen is now validating further. Crazy to think that rejecting 2-73 is the predominant possibility and not the possibility that a partnership with Biogen is possible.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News